Abstract
In this work, 125I-labeled cholera toxin B-subunit (CT-B) (specific activity 98 Ci/mmol) was prepared, and its high-affinity binding to human blood T-lymphocytes (K d = 3.3 nM) was determined. The binding of the 125I-labeled CT-B was inhibited by unlabeled interferon-α2 (IFN-α2), thymosin-α1 (TM-α1), and by the synthetic peptide LKEKK, which corresponds to sequences 16-20 of human TM-α1 and 131-135 of IFN-α2 (K i 0.8, 1.2, and 1.6 nM, respectively), but was not inhibited by the unlabeled synthetic peptide KKEKL with inverted sequence (K i > 1 μM). In the concentration range of 10-1000 nM, both CT-B and peptide LKEKK dose-dependently increased the activity of soluble guanylate cyclase (sGC) but did not affect the activity of membrane-bound guanylate cyclase. The KKEKL peptide tested in parallel did not affect sGC activity. Thus, the CT-B and peptide LKEKK binding to a common receptor on the surface of T-lymphocytes leads to an increase in sGC activity.
Similar content being viewed by others
Abbreviations
- cGMP:
-
cyclic guanosine monophosphate
- CT-B:
-
cholera toxin B-subunit
- HPLC:
-
high performance liquid chromatography
- IFN:
-
interferon
- IL:
-
interleukin
- iNOS:
-
inducible NO-synthase
- K d :
-
equilibrium dissociation constant
- K i :
-
inhibition constant
- mGC:
-
membrane-bound guanylate cyclase
- PMSF:
-
phenylmethylsulfonyl fluoride
- sGC:
-
soluble guanylate cyclase
- TM-α1:
-
thymosin-α1
References
Zav’yalov, V. P., Navolotskaya, E. V., Abramov, V. M., Galaktionov, V. G., Isaev, I. S., Kaurov, O. A., Kozhich, A. T., Maiorov, V. A., Prusakov, A. N., Vasilenko, R. N., and Volodina, E. Y. (1991) The octapeptide corresponding to the region of the highest homology between α-interferon and thymosin-α1 effectively competes with both cytokines for common high-affinity receptors on murine thymocytes, FEBS Lett., 278, 187–189.
Zav’yalov, V. P., Navolotskaya, E. V., Vasilenko, R. N., Abramov, V. M., Volodina, E. Y., Roslovtseva, O. A., Prusakov, A. N., and Kaurov, O. A. (1995) The sequence 130-137 of human interferon-α2 is involved in the competition of interferon, prothymosin α and cholera toxin B subunit for common receptors on human fibroblasts, Mol. Immunol., 32, 425–431.
Navolotskaya, E. V., Zinchenko, D. V., Zolotarev, Y. A., Kolobov, A. A., and Lipkin, V. M. (2016) Binding of synthetic LKEKK peptide to human T-lymphocytes, Biochemistry (Moscow), 81, 871–875.
Salacinski, P. R., McLean, C., Sykes, J. E., ClementJones, V. V., and Lowry, P. J. (1981) Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1, 3, 4, 6-tetrachloro-3 alpha, 6 alpha-diphenyl glycoluril (Iodogen), Anal. Biochem., 117, 136–146.
Boyum, A., Berg, T., and Blomhoff, R. (1983) in Iodinated Density Gradient Media–A Practical Approach (Rickwood, D., ed.) Oxford, pp. 147–170.
Patel, D., Rubbi, C. P., and Rickwood, D. (1995) Separation of Tand B-lymphocytes from human peripheral blood mononuclear cells using density perturbation methods, Clin. Chim. Acta, 240, 187–193.
Pennock, B. E. (1973) A calculator for finding binding parameters from a Scatchard plot, Anal. Biochem., 56, 306–309.
Cheng, Y. C., and Prusoff, W. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction, Biochem. Pharmacol., 22, 3099–3108.
Carpentieri, U., Minguell, J. J., and Gardner, F. H. (1981) Adenylate cyclase and guanylate cyclase activity in normal and leukemic human lymphocytes, Blood, 57, 975–978.
Schultz, G., and Bohme, E. (1984) in Methods of Enzymatic Analysis, Verlag Chemie, Weinheim, Germany, pp. 379–389.
Southam, E. (2001) Measurement of cGMP and soluble guanylyl cyclase activity, Curr. Protoc. Toxicol., 10, 10.5.
Lowry, O. H., Rosebrough, N. J., Farr, O. L., and Randal, R. J. (1951) Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265–275.
Lonnroth, I., and Holmgren, J. (1973) Subunit structure of cholera toxin, J. Gen. Microbiol., 76, 417–427.
Merritt, E. A., Sarfaty, S., Akker, F. V. D., L’Hoir, C., Martial, J. A., and Hol, W. G. J. (1994) Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide, Protein Sci., 3, 166–175.
Chester, M. A. (1998) IUPAC-IUB joint commission on biochemical nomenclature (JCBN). Nomenclature of glycolipids–recommendations 1997, Eur. J. Biochem., 257, 293–298.
Holmgren, J., Lonnroth, I., and Svennerholm, L. (1973) Tissue receptor for cholera exotoxin: postulated structure from studies with G Mganglioside and related glycolipids, Infect. Immun., 8, 208–214.
Schoen, A., and Freire, E. (1989) Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1, Biochemistry, 8, 5019–5024.
Kozireski-Chuback, D., Wu, G., and Ledeen, R. W. (1999) Developmental appearance of nuclear GM1 in neurons of the central and peripheral nervous systems, Dev. Brain Res., 115, 201–208.
Baldauf, K. J., Royal, J. M., Hamorsky, K. T., and Matoba, N. (2015) Cholera toxin B: one subunit with many pharmaceutical applications, Toxins, 7, 974–996.
Stratmann, T. (2015) Cholera toxin subunit B as adjuvant–an accelerator in protective immunity and a break in autoimmunity, Vaccines (Basel), 3, 579–596.
Navolotskaya, E. V., Sadovnikov, V. B., Zinchenko, D. V., Vladimirov, V. I., Zolotarev, Y. A., and Kolobov, A. A. (2016) The LKEKK synthetic peptide as a ligand of rat intestinal epithelial cell membranes, Russ. J. Bioorg. Chem., 42, 479–483.
Kots, A. Y., Martin, E., Sharina, I. G., and Murad, F. (2009) A short history of cGMP, guanylyl cyclases, and cGMP-dependent protein kinases, Handb. Exp. Pharmacol., 191, 1–14.
Kuhn, M. (2016) Molecular physiology of membrane guanylyl cyclase receptors, Physiol. Rev., 96, 751–804.
Niedbala, W., Cai, B., and Liew, F. Y. (2006) Role of nitric oxide in the regulation of T-cell functions, Ann. Rheumatic Dis., 65, 37–40.
Nath, N., Morinaga, O., and Singh, I. (2010) SNitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis, J. Neuroimmune Pharmacol., 5, 240–251.
Lee, S. W., Choi, H., Eun, S. Y., Fukuyama, S., and Croft, M. (2011) Nitric oxide modulates TGF-β-directive signals to suppress Foxp3+ regulatory T cell differentiation and potentiate Th1 development, J. Immunol., 186, 6972–6980.
Yang, J., Zhang, R., Lu, G., Shen, Y., Peng, L., Zhu, C., Cui, M., Wang, W., Arnaboldi, P., Tang, M., Gupta, M., Qi, C. F., Jayaraman, P., Zhu, H., Jiang, B., Chen, S. H., He, J. C., Ting, A. T., Zhou, M. M., Kuchroo, V. K., Morse, H. C., Ozato, K., Sikora, A. G., and Xiong, H. (2013) T-cellderived inducible nitric oxide synthase switches off Th17 cell differentiation, J. Exp. Med., 210, 1447–1462.
Valenti, L., Mathieu, J., Chancerelle, Y., Levacher, M., Chanaud, B., De Sousa, M., Strzalko, S., Dinh-Xuan, A. T., Giroud, J. P., and Florentin, I. (2003) Nitric oxide inhibits spleen cell proliferative response after burn injury by inducing cytostasis, apoptosis, and necrosis of activated T-lymphocytes: role of the guanylate cyclase, Cell. Immunol., 221, 50–63.
Niedbala, W., Wei, X. Q., Piedrafita, D., Xu, D., and Liew, F. Y. (1999) Effects of nitric oxide on the induction and differentiation of Th1 cells, Eur. J. Immunol., 29, 2498–2505.
Niedbala, W., Wei, X. Q., Campbell, C., Thomson, D., Komai-Koma, M., and Liew, F. Y. (2002) Nitric oxide preferentially induces type 1 T-cell differentiation by selectively up-regulating IL-12 receptor β2 expression via cGMP, Proc. Natl. Acad. Sci. USA, 99, 16186–16191.
Wei, X. Q., Charles, I. G., Smith, A., Ure, J., Feng, G. J., Huang, F. P., Xu, D., Muller, W., Moncada, S., and Liew, F. Y. (1995) Altered immune responses in mice lacking inducible nitric oxide synthase, Nature, 375, 408–411.
McInnes, I. B., Leung, B., Wei, X. Q., Gemmell, C. C., and Liew, F. Y. (1998) Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase, J. Immunol., 160, 308–315.
MacLean, A., Wei, X. Q., Huang, F. P., Al-Alem, U. A., Chan, W. L., and Liew, F. Y. (1998) Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses, J. Gen. Virol., 79, 825–830.
Huang, F. P., Niedbala, W., Wei, X. Q., Xu, D., Feng, G. J., Robinson, J. H., Lam, C., and Liew, F. Y. (1998) Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages, Eur. J. Immunol., 28, 4062–4070.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E. V. Navolotskaya, V. B. Sadovnikov, D. V. Zinchenko, Y. A. Zolotarev, V. M. Lipkin, V. P. Zav'yalov4, 2017, published in Biokhimiya, 2017, Vol. 82, No. 9, pp. 1330-1337.
Rights and permissions
About this article
Cite this article
Navolotskaya, E.V., Sadovnikov, V.B., Zinchenko, D.V. et al. Interaction of cholera toxin B-subunit with human T-lymphocytes. Biochemistry Moscow 82, 1036–1041 (2017). https://doi.org/10.1134/S0006297917090061
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297917090061